Immune to Cancer: The CRI Blog
-
Introducing CRI’s Cancer Immunotherapy Insights + Impact Report 2025: Evolution of Immunotherapy, FDA Approvals & Next-Generation Treatment Trends
As a scientist who has spent the better part of my career thinking about the prevention, diagnosis,… -
Cancer Immunotherapy Insights + Impact 2025 Report
A Decade of Progress. A Future of Possibility. The Cancer Research Institute (CRI)’s 2025 Cancer Immunotherapy Insights… -
2025 AACR-CRI Lloyd J. Old Award: Dr. Crystal Mackall Honored for Fearlessly Confronting the “Beast” of Cancer
The Cancer Research Institute (CRI) and the American Association for Cancer Research (AACR) have awarded Dr. Crystal… -
Immunotherapy vs. Chemotherapy: What’s the Difference?
We answer common questions patients ask about how immunotherapy compares to chemotherapy, including side effects and length…
-
Fighting Colorectal Cancer with Immunotherapy: What You Need to Know
While colorectal cancer (CRC) is the third most diagnosed cancer and the third leading cause of cancer… -
Saving Research, Saving Lives: Fighting for the Future of Cancer Science Amid NIH Disruptions
At the Cancer Research Institute (CRI), we recognize the National Institutes of Health (NIH) as a cornerstone… -
Riding Through It: How Immunotherapy and His Bike Helped Thomas Vibert Beat Stage 4 Colon Cancer
March is Colorectal Cancer Awareness Month, a time to spotlight perseverance, advocacy, and groundbreaking treatments like immunotherapy…. -
“We’ve Always Been Here” – A Personal Reflection on Female Scientists for Women’s History Month
This March, I’d like to take a moment to reflect on, acknowledge, and amplify the contributions of… -
Colorectal Cancer Rates Are Skyrocketing in Young Adults—Is Your Lifestyle Putting You at Risk?
In the United States, colorectal cancer (CRC) is the third most diagnosed cancer and the third leading…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.